What is he best known for?
The fields of study he is best known for:
- Organic chemistry
- Polymer
- Biochemistry
His primary areas of study are Drug delivery, Nanoparticle, Nanotechnology, Biocompatibility and Biophysics.
His Drug delivery study incorporates themes from Click chemistry, Surface modification, Biodistribution, Permeation and Mucoadhesion.
His Nanoparticle research is multidisciplinary, incorporating perspectives in Porous silicon and Stereochemistry.
In his study, Microfluidics, Dispersity and Extrusion is inextricably linked to Polymer, which falls within the broad field of Nanotechnology.
His biological study spans a wide range of topics, including Combination chemotherapy and In vitro.
His Biophysics research includes themes of Chitosan, Membrane and Drug carrier.
His most cited work include:
- Biocompatibility of Thermally Hydrocarbonized Porous Silicon Nanoparticles and their Biodistribution in Rats (241 citations)
- Drug permeation across intestinal epithelial cells using porous silicon nanoparticles (132 citations)
- In vitro cytotoxicity of porous silicon microparticles: effect of the particle concentration, surface chemistry and size. (132 citations)
What are the main themes of his work throughout his whole career to date?
Ermei Mäkilä mostly deals with Drug delivery, Nanotechnology, Nanoparticle, Porous silicon and Biocompatibility.
His work deals with themes such as Controlled release, Biophysics, Surface modification and Biomedical engineering, which intersect with Drug delivery.
The study incorporates disciplines such as Cell, Insulin and Permeation in addition to Biophysics.
The concepts of his Nanotechnology study are interwoven with issues in Chitosan, Cancer cell and Polymer.
His Nanoparticle research integrates issues from Conjugated system, In vitro, Biodistribution and Undecylenic acid.
His Porous silicon research includes elements of Carbonization and Dextran.
He most often published in these fields:
- Drug delivery (63.64%)
- Nanotechnology (53.59%)
- Nanoparticle (52.63%)
What were the highlights of his more recent work (between 2017-2021)?
- Nanoparticle (52.63%)
- Porous silicon (43.54%)
- Drug delivery (63.64%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Nanoparticle, Porous silicon, Drug delivery, Nanotechnology and Biophysics.
His biological study spans a wide range of topics, including Biomaterial and Cell biology.
The study incorporates disciplines such as Characterization, Spice, Carbonization and Cell membrane in addition to Porous silicon.
The various areas that Ermei Mäkilä examines in his Drug delivery study include Drug, Biocompatibility, Doxorubicin, Endocytosis and Biomedical engineering.
His study in the field of Colloidal gold and Photothermal therapy also crosses realms of Glial cell line-derived neurotrophic factor and Parkinson's disease.
His Biophysics research incorporates elements of Cell, Controlled release, Insulin, Transcytosis and Nanomedicine.
Between 2017 and 2021, his most popular works were:
- Multifunctional Nanohybrid Based on Porous Silicon Nanoparticles, Gold Nanoparticles, and Acetalated Dextran for Liver Regeneration and Acute Liver Failure Theranostics (46 citations)
- Photothermal-responsive nanosized hybrid polymersome as versatile therapeutics codelivery nanovehicle for effective tumor suppression. (35 citations)
- Gold Nanorods Conjugated Porous Silicon Nanoparticles Encapsulated in Calcium Alginate Nano Hydrogels Using Microemulsion Templates. (33 citations)
In his most recent research, the most cited papers focused on:
- Organic chemistry
- Biochemistry
- Polymer
The scientist’s investigation covers issues in Drug delivery, Nanoparticle, Nanotechnology, Drug and Porous silicon.
His Drug delivery research is multidisciplinary, incorporating perspectives in Microfluidics, Doxorubicin, Fc receptor, Transcytosis and Nanomedicine.
His Nanoparticle research includes elements of Biophysics, Insulin and Controlled release.
His work carried out in the field of Nanotechnology brings together such families of science as Chitosan and Dextran.
His work deals with themes such as In vitro model, Gastrointestinal tract and Nanocomposite, which intersect with Drug.
His Porous silicon study integrates concerns from other disciplines, such as Characterization, Carbonization, Optical sensing and Surface modification.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
